Kongressbeiträge

Tauber N, Fick F, Muras K, Kohls F, Hilmer L, Rody A, Banys-Paluchowski M et al. Axilläre De-Eskalation beim frühen Brustkrebs: die INSEMA- und SOUND-Studie im multizentrischen und retrospektiven Real-World Vergleich 

Kohls F, Muras K, Tauber N, Rody A, Banys-Paluchowski M. Fallbericht: Nippelsparende Mastektomie in Form einer Reduktionsfigur mod. nach McKissock

Tauber N, Banys-Paluchowski M, Conrad A, Hesse T, Iwersen M, Kaiser S, Laakmann E, van Mackelenbergh MT, Ries E, Rody A, Tribian N, Wiechmann S, Wimmer-Freys K, Elessawy M. Assessment of Treatment and Decision-Making Structures for Patients with Early HR+/HER2– Breast Cancer in Germany: The TOGETHER Survey. ePoster 37. Deutscher Krebskongress 2026.

Tauber N, Banys-Paluchowski M, Schäffler H, Dannehl D, Elessawy M, Fick F, Gasthaus C, Grande-Nagel I, Hemptenmacher F, Hilmer L, Kohls F, Krawczyk N, Duc Le H, Maas N, Princk H, Rody A, Schäfer KWF, Steinhilper L, van Mackelenbergh M, Rambow AC. Travel and time toxicity of axillary sentinel lymph node marking at two certified university breast cancer centers in Schleswig-Holstein, Germany: an economic and ecologic assessment based on the INSEMA and SOUND study. ePoster ESMO-Congress 2025. Annals of Oncology 2025, 36, S384, doi:10.1016/j.annonc.2025.08.868.

Tauber N, Banys-Paluchowski M, Krawczyk N, Scharf JL, Rody A, Cirkel C. Preferences of medical students for digital teaching in obstetrics and gynecology education. European Journal of Obstetrics and Gynecology and Reproductive Biology 2025, 313, doi:10.1016/j.ejogrb.2025.114203. selected oral presentation

Tauber N, Hilmer L, Dannehl D, Fick F, Hemptenmacher F, Krawczyk N, Meyer-Lehnert T, Milewski K, Princk H, Hartkopf A, Rody A, Banys-Paluchowski M. Früher Brustkrebs: wie viele Patientinnen sind potentielle Kandidatinnen einer kombinierten endokrinen Therapie? Senologie 2025; 22(02): 32 - 32. doi:10.1055/s-0045-1807703.

Schäffler H, Heublein S, Pfister K, Lukac S, Rack B, Janni W, Hartkopf A, Engler T, Brucker S, Hilmer L, Rody A, Banys-Paluchowski M, Dannehl D, Tauber N. Time Toxicity of Endocrine-Based Oral CDK4/6 Inhibitor Therapies. Vortragspreis

Fick F, Lenz F, Sailer VW, Muras K, Tauber N, Rody A, Hemptenmacher F, Ribbat-Idel J, Krawczyk N, Banys-Paluchowski M. AXINEO: AXIllary response to NEOadjuvant chemotherapy for breast cancer: Can we predict response based on a biomarker panel?

Kaschner K, Banys-Paluchowski M, Rody A, Tauber N, Fick F, Gembicki M, Weichert J, Kaiser AK. Schwangerschaftseintritt unter Tamoxifen. Senologie 2025; 22(02): 17 - 17. doi:10.1055/s-0045-1807668.

Ryu JM, Kühn T, Ditsch N, Harvey J, Hartmann S, Cabioglu N, …, Tauber N, Banys-Paluchowski M. Methods for Localization of Different Types of Breast Lesions. A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET, NCT05559411). Abstract San Antonio Breast Cancer Symposium 2025.  

Banys-Paluchowski M, Ditsch N, Kühn T and MELODY study group (Tauber N) et al. MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4 / iBRA-NET / AGO-B-062, NCT 05559411). Journal of Clinical Oncology 2025, 43, TPS627-TPS627, doi:10.1200/JCO.2025.43.16_suppl.TPS627.

Banys-Paluchowski M, Hartmann S, Ditsch N, de Boniface J, Gentilini OD and the AXSANA Study Group (Tauber N et al.) et al. Comparison of marking techniques for target lymph nodes in 2,596 patients with node-positive breast cancer treated with neoadjuvant chemotherapy - Results from the prospective multicenter AXSANA / EUBREAST-03 / AGO-B-053 study (NCT04373655). Journal of Clinical Oncology 2025, 43, 503-503, doi:10.1200/JCO.2025.43.16_suppl.503. 

Banys-Paluchowski M, Kühn T, Masannat Y, Ditsch N, Cabioglu N, Havey J, Pankratjevaite L, Murawa D, Gasparri ML, MELODY Study Group (Tauber N). MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4 / iBRA-NET). Abstract ASCO 2024. 

Fick F, Jost N, Matlac DM, Milewski K, Tauber N, Banys-Kotomska J, Krawczyk N, Rody A, Hemptenmacher F, Hanker L, Banys-Paluchowski M. BrEast cancer in the VEry elderLY (BEVERLY-1): Therapy recommendations, patient compliance and survival. Abstract Deutscher Senologie-Kongress 2024.

Jost N, Fick F, Matlac DM, Milewski K, Tauber N, Banys-Kotomska J, Krawczyk N, Rody A, Hemptenmacher F, Hanker L, Banys-Paluchowski M. BrEast cancer in the VEry eldeRLY (BEVERLY-1): Patient characteristics, co-morbidities, drug intake and guideline adherence. Abstract Deutscher Senologie-Kongress 2024.

Kopperschmidt V, Paluchowski P, Rody A, Krawcyzk N, Hanker L, Hemptenmacher F, Banys-Paluchowski M. Evaluation der Langzeittrends in der Implantat- und Netzbasierten Brustchirurgie. AWOgyn-Jahrestagung 2024

Fick F., Kaschner K., Banys Paluchowski M., Schiemenz C., Belousova V., Rody A., Princk M.H., Bilateral papilledema and vision loss under adjuvant chemotherapy with Carboplatin and Doxetaxel a rare presentation of central neurotoxicity